Table 5 Anti-inflammatory assay of PE and CNF/PVA composite reinforced with PE at different concentrations.
Hemolysis inhibition (%) at different concentrations | ||||||
|---|---|---|---|---|---|---|
Sample | 1000 (µg/mL) | 800 (µg/mL) | 600 (µg/mL) | 400 (µg/mL) | 200 (µg/mL) | 100 (µg/mL) |
PE | 88.8 ± 1.312 | 83.4 ± 1.314 | 80.5 ± 2.213 | 76.2 ± 1.523 | 74.9 ± 2.319 | 72.6 ± 1.942 |
CNF/PVA | 79.4 ± 2.002 | 76.1 ± 2.504 | 72.3 ± 2.003 | 69.8 ± 1.803 | 66.9 ± 2.009 | 64.3 ± 3.104 |
CNF/PVA/PE1 | 82.1 ± 2.002 | 80.7 ± 1.004 | 78.4 ± 1.603 | 75.3 ± 3.003 | 72.2 ± 3.309 | 68.4 ± 2.014 |
CNF/PVA/PE2 | 88.3 ± 2.472 | 85.2 ± 2.934 | 80.8 ± 2.603 | 78.5 ± 3.053 | 74.1 ± 1.029 | 70.2 ± 3.004 |
Positive control | 100 ± 2.362 | |||||
